Weight & Metabolism
Midlife weight change, GLP-1 medications, and the body-composition claims made for peptides.
GLP-1 medications for menopause-related weight gain: what to know
What actually changes about weight and body composition through the menopause transition, how GLP-1 medications (semaglutide and tirzepatide) work, what the weight-loss evidence shows, and why menopause-specific data is still limited, a sourced, non-promissory guide to exploring the option with a licensed provider.
Peptides for weight loss for women: what midlife women are using, and how much evidence sits behind each
What women in perimenopause and menopause are actually using for weight loss, from approved GLP-1s like Wegovy and Zepbound to MOTS-c, 5-Amino-1MQ and tesamorelin. How much evidence sits behind each, whether women were ever studied, side effects women report, and what the online conversation gets right and wrong.
Sermorelin for women: what to know
Sermorelin keeps showing up in women's anti-aging feeds. Here is what it is, what the adult studies (including one that enrolled women aged 55 to 71) actually found, its side effects, how it compares with tesamorelin, and what women in midlife should weigh first.